Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer

Cervical cancer (CC) poses a serious threat to women’s health. Although many early-stage patients have a good prognosis, there are still a lack of effective therapies for advanced and recurrent/metastatic CC. In this context, immunotherapy and immune checkpoint inhibitors (ICIs) are particularly lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xiling, Chang, Wei-wei, Xia, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582347/
https://www.ncbi.nlm.nih.gov/pubmed/36276090
http://dx.doi.org/10.3389/fonc.2022.996495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582347/
https://www.ncbi.nlm.nih.gov/pubmed/36276090
http://dx.doi.org/10.3389/fonc.2022.996495

Ejemplares similares